Trajan Group Holdings (ASX:TRJ) shares have surged 16.67% over the past five trading days, with the stock last trading at $0.21, up 2.44% on the day. The rally follows a financial year in which the analytical science company reported a decline in full-year Revenue and earnings, but with a notably stronger second half, making this a useful case study in how a Business with a difficult start to the year can still see renewed investor interest based on its trajectory.

About the Company

Trajan Group Holdings Limited is a global analytical science and device company, designing and Manufacturing components, consumables and equipment used in scientific analysis and testing across sectors including environmental testing, food safety, pharmaceuticals and diagnostics. The company operates across segments including Components and Consumables, Disruptive Technologies and Capital Equipment, with manufacturing and operational footprints spanning multiple countries. In recent periods, Trajan has been executing a company-wide cost efficiency and Margin improvement program known as Project Neptune.

Key Developments

Trajan's FY26 results showed a full-year decline offset by a notably stronger second half. Full-year Group revenue declined 3.1% to $161.4 million, and full-year Group normalised EBITDA (nEBITDA) fell 14.7% to $13.2 million. The company said the result reflected a difficult opening quarter, though performance improved from the second quarter onward. H2 FY26 nEBITDA was $8.1 million, up 61.8% on H1 FY26's $5.0 million, with H2 proforma gross margin improving 3.2 percentage points to 40.6% from 37.4% in H1. The company noted that appreciation of the Australian dollar during the second half affected the translation of overseas earnings, with an estimated impact of approximately $5.0 million in revenue and $2.4 million in nEBITDA; excluding this effect, revenue and nEBITDA were within 2.5% of updated guidance provided in May 2026. Margin improvement was attributed to the company's Project Neptune program, including workforce resizing, footprint rationalisation, manufacturing automation and increased operational transfer to Malaysia, which together delivered a combined $2.4 million uplift in the second half. Capital Expenditure was reduced to $3.4 million from $4.1 million, with the company maintaining a stable cash balance of $12.6 million. Given the momentum since the second quarter, Trajan expects mid-single digit organic revenue growth and double-digit nEBITDA growth in FY27.

Bull Case

The bull case for Trajan centres on the clear and accelerating improvement seen through the second half of FY26, with nEBITDA up 61.8% on the first half and gross margin expanding 3.2 percentage points. This improvement reflects tangible progress under the company's Project Neptune cost efficiency program, including workforce resizing, footprint rationalisation and increased manufacturing automation, initiatives that management expects to continue delivering benefits into FY27. The company's guidance for mid-single digit organic revenue growth and double-digit nEBITDA growth in FY27 suggests confidence that the second-half momentum can be sustained across a full year, rather than being a temporary improvement. A reduced capital expenditure requirement and stable cash balance also indicate the business is being run with financial discipline through this transition period.

Bear Case

The bear case notes that despite the second-half improvement, full-year revenue and nEBITDA both declined for FY26, meaning the company has not yet returned to its prior growth trajectory on an annual basis. The Capital Equipment segment continued to face weakness tied to funding conditions and food market Volatility in North America, along with the discontinuation of Certus revenue, resulting in a loss of approximately $2.1 million in FY26, a headwind that may take further time to fully resolve. Currency movements, specifically Australian dollar appreciation, materially affected reported results during the second half, illustrating how sensitive the company's Earnings remain to Exchange Rate fluctuations given its global operations.

Risks

Key risks for Trajan include continued softness in its Capital Equipment segment, particularly given the ongoing challenges tied to North American funding conditions and food market volatility that affected results in FY26. The company remains exposed to currency movements given its global manufacturing and sales footprint, with Australian dollar strength already having a measurable negative effect on translated earnings during the year. Execution risk on the continued rollout of Project Neptune initiatives, including further automation, ERP integration and manufacturing transfer to Malaysia, could affect whether the anticipated cost efficiencies are fully realised. Order book trends, while reported as returning to previous levels, will need to translate into sustained revenue growth to support the FY27 guidance.

Conclusion

Trajan's FY26 results illustrate a year of two distinct halves, with a weak opening quarter and adverse currency movements weighing on full-year revenue and earnings, offset by a pronounced recovery in margins and profitability through the second half as Project Neptune cost initiatives took hold. With guidance pointing to renewed organic revenue growth and double-digit nEBITDA growth in FY27, the company's near-term performance will likely hinge on whether the cost efficiencies and margin gains delivered in the second half can be sustained across a full financial year. For investors considering the 16.67% weekly rally, the second-half trajectory reported for FY26 appears to provide a reasonable basis for renewed optimism, though the full-year decline is a reminder that the turnaround is still a work in progress rather than a completed story.